Seely Lynn 4
4 · Lyell Immunopharma, Inc. · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Seely Lynn
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-11-10$16.11/sh−412$6,637→ 67,159 total
Footnotes (1)
- [F1]Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.